BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$725M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$694M |
| 3 |
Microsoft
MSFT
|
+$320M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$216M |
| 5 |
Amazon
AMZN
|
+$211M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$153M |
| 2 |
Bank of America
BAC
|
+$130M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$62.1M |
| 4 |
STJ
St Jude Medical
STJ
|
+$55.6M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$50.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.95% |
| 2 | Financials | 11.02% |
| 3 | Healthcare | 9.12% |
| 4 | Communication Services | 8.65% |
| 5 | Consumer Discretionary | 7.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Seaboard Corp
SEB
$4.02B
| $4.17K | ﹤0.01% |
1
-11
| -92% | -$43K |
|
3302
Travere Therapeutics
TVTX
$5.86B
| $4.15K | ﹤0.01% |
225
-1,807
| -89% | -$35.3K |
|
3303
CytomX Therapeutics
CTMX
$760M
| $4.14K | ﹤0.01% |
240
-978
| -80% | -$12.9K |
|
3304
Turkcell
TKC
$4.74B
| $4.14K | ﹤0.01% |
500
| – | – |
|
3305
Seres Therapeutics
MCRB
$47.4M
| $4.14K | ﹤0.01% |
18
-11
| -38% | -$2.23K |
|
|
YELL
3306
DELISTED
Yellow Corporation Common Stock
YELL
| $4.07K | ﹤0.01% |
370
-1,309
| -78% | -$17K |
|
|
IBTX
3307
DELISTED
Independent Bank Group, Inc.
IBTX
| $4.05K | ﹤0.01% |
63
-576
| -90% | -$36.3K |
|
|
FBRC
3308
DELISTED
FBR & Co. Common Stock
FBRC
| $4.04K | ﹤0.01% |
224
-166
| -43% | -$2.67K |
|
3309
Middlesex Water
MSEX
$1.1B
| $4.03K | ﹤0.01% |
109
-193
| -64% | -$7.21K |
|
3310
Omega Flex
OFLX
$304M
| $4.01K | ﹤0.01% |
84
-112
| -57% | -$5.29K |
|
3311
Independent Bank Corp
IBCP
$850M
| $4K | ﹤0.01% |
193
-1,211
| -86% | -$25.6K |
|
3312
ING
ING
$102B
| $3.97K | ﹤0.01% |
263
-4
| -1% | -$59 |
|
3313
Chegg
CHGG
$88.9M
| $3.96K | ﹤0.01% |
469
-906
| -66% | -$6.99K |
|
3314
QCR Holdings
QCRH
$1.73B
| $3.94K | ﹤0.01% |
93
-842
| -90% | -$36K |
|
|
ADPT
3315
DELISTED
Adeptus Health Inc
ADPT
| $3.92K | ﹤0.01% |
2,180
-328
| -13% | -$1.84K |
|
|
TRK
3316
DELISTED
Speedway Motorsports, Inc.
TRK
| $3.92K | ﹤0.01% |
208
-1,050
| -83% | -$21.8K |
|
3317
Angi Inc
ANGI
$176M
| $3.91K | ﹤0.01% |
69
-214
| -76% | -$13.6K |
|
|
COUP
3318
DELISTED
Coupa Software Incorporated
COUP
| $3.89K | ﹤0.01% |
+153
| New | +$3.91K |
|
|
PCMI
3319
DELISTED
PCM, Inc
PCMI
| $3.84K | ﹤0.01% |
137
+14
| +11% | +$357 |
|
|
WMAR
3320
DELISTED
West Marine Inc
WMAR
| $3.83K | ﹤0.01% |
401
-503
| -56% | -$4.75K |
|
3321
Cytokinetics
CYTK
$10.5B
| $3.75K | ﹤0.01% |
292
-1,613
| -85% | -$18.9K |
|
3322
Immunic
IMUX
$217M
| $3.75K | ﹤0.01% |
2
+1
| +100% | +$1.83K |
|
|
PRO
3323
DELISTED
PROS Holdings
PRO
| $3.75K | ﹤0.01% |
155
-1,257
| -89% | -$28.4K |
|
3324
NMI Holdings
NMIH
$3.38B
| $3.74K | ﹤0.01% |
328
-2,848
| -90% | -$31.2K |
|
3325
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$5.37B
| $3.74K | ﹤0.01% |
185
-614
| -77% | -$11.8K |
|
Similar funds
BNP Paribas Financial Markets's Q1 2017 Portfolio in Review
As of Q1 2017, BNP Paribas Financial Markets held 4,403 positions worth $37.9B, up 77% from $21.3B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $14.9B of net new capital in Q1 2017, opening 244 new positions and adding to 1,412 existing holdings. Its largest new stake was State Street SPDR S&P Metals & Mining ETF: 1,526,590 shares worth $46.4M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 9.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares US Real Estate ETF, an estimated $153M trimmed.
- BNP Paribas Financial Markets's largest Q1 2017 buy was State Street SPDR S&P Metals & Mining ETF: 1,526,590 shares worth $46.4M.
- BNP Paribas Financial Markets added most to Apple in Q1 2017, an estimated $725M increase.
- BNP Paribas Financial Markets's biggest Q1 2017 reduction was iShares US Real Estate ETF, cutting an estimated $153M.
- BNP Paribas Financial Markets fully exited St Jude Medical in Q1 2017, selling an estimated $55.6M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $37.9B portfolio in Q1 2017.
- BNP Paribas Financial Markets opened 244 new positions and closed 335 in Q1 2017.
- BNP Paribas Financial Markets's portfolio value rose 77% quarter-over-quarter to $37.9B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2017, filed 3 May 2017.